Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

En studie av Niraparib i kombinasjon med abirateronacetat og prednison versus abirateronacetat og prednison for behandling av deltakere med skadelig kimlinje eller somatisk homolog rekombinasjonsreparasjon (HRR) genmutert metastatisk kastrasjonssensitiv prostatakreft (mCSPC) (AMPLITUDE)

2. november 2026 oppdatert av: Janssen Research & Development, LLC

En fase 3 randomisert, placebokontrollert, dobbeltblind studie av Niraparib i kombinasjon med abirateronacetat og prednison versus abirateronacetat og prednison for behandling av deltakere med skadelig kimlinje eller somatisk homolog rekombinasjonsreparasjon (HRR) genkastermutert metastasittiv metastasering. Prostatakreft (mCSPC)

The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in participants with deleterious germline or somatic Homologous Recombination Repair (HRR) gene-mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) provides superior efficacy in improving radiographic progression-free survival (rPFS).

Studieoversikt

Studietype

Intervensjonell

Registrering (Faktiske)

696

Fase

  • Fase 3

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Buenos Aires, Argentina, C1419AHN
        • Asociacion de Beneficencia Hospital Sirio Libanes
      • Buenos Aires, Argentina, C1426AGE
        • Centro Oncológico Korben
      • Buenos Aires, Argentina, C1061AAS
        • CIPREC
      • C.a.b.a., Argentina, C1426BOR
        • Hospital Militar Cosme Argerich
      • Caba, Argentina, C1056ABI
        • CINME Centro de Investigaciones Metabolicas
      • Ciudad Automoma Buenos Aires, Argentina, C1120AAT
        • Centro de Urologia (CDU)
      • Ciudad Autonoma de, Argentina, C1199ABB
        • Hospital Italiano de Buenos Aires
      • Ciudad de Buenos Aires, Argentina, C1430EGF
        • Clinica Adventista Belgrano
      • Córdoba, Argentina, 5000
        • Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica
      • Córdoba, Argentina, X5000KPH
        • Centro Urologico Profesor Bengio
      • Córdoba, Argentina, X5800
        • Instituto Médico de Río Cuarto
      • Córdoba, Argentina, XX5016KEH
        • Hospital Privado de Cordoba
      • Mar del Plata, Argentina, B7602CBM
        • Hospital Privado de Comunidad
      • Pergamino, Argentina, B2700CPM
        • Centro de Investigacion Pergamino SA
      • San Salvador de Jujuy, Argentina, Y4600AFW
        • ARS Médica
      • Birtinya, Australia, 4575
        • Sunshine Coast University Hospital
      • Darlinghurst, Australia, 2010
        • St Vincent s Hospital Sydney
      • Herston, Australia, 4029
        • Cancer Care Services Clinical Research Unit
      • Hobart, Australia, 7000
        • Royal Hobart Hospital
      • Kurralta Park, Australia, 5037
        • Icon Cancer Centre Kurralta Park
      • Liverpool, Australia, 2170
        • Liverpool Hospital
      • Melbourne, Australia, 3000
        • Peter MacCallum Cancer Centre
      • Murdoch, Australia, 6150
        • Fiona Stanley Hospital
      • North Ryde, Australia, 2109
        • Macquarie University Hospital
      • South Brisbane, Australia, 4101
        • ICON Cancer Care
      • Subiaco, Australia, 6008
        • St John of God Subiaco Hospital
      • Antwerp, Belgia, 2020
        • ZNA Middelheim
      • Antwerp, Belgia, 2610
        • ZAS Augustinus
      • Charleroi, Belgia, 6060
        • Grand Hopital De Charleroi Site Les Viviers
      • Haine-St-Paul, Belgia, 7100
        • Jolimont
      • Liège, Belgia, 4000
        • CHC MontLegia
      • Namur, Belgia, 5000
        • CHU UCL Namur - Site Sainte Elisabeth
      • Ottignies, Belgia, 1340
        • Clinique St Pierre
      • Roeselare, Belgia, 8800
        • Algemeen Ziekenhuis Delta
      • Barretos, Brasil, 14784-400
        • Fundacao Pio XII
      • Belo Horizonte, Brasil, 30110-022
        • Cetus Oncologia
      • Belo Horizonte, Brasil, 30130-090
        • PERSONAL Oncologia de Precisao e Personalizada
      • Curitiba, Brasil, 80810 050
        • CIONC Centro Integrado de Oncologia de Curitiba
      • Florianópolis, Brasil, 88020 210
        • Grupo ELORA Centro de Pesquisa e Ensino em Saude de Santa Catarina
      • Fortaleza, Brasil, 60 810180
        • Pronutrir
      • Goiânia, Brasil, 74605-070
        • Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
      • Ipatinga, Brasil, 35162 189
        • Fundacao Sao Francisco Xavier
      • Joinville, Brasil, 89201-260
        • Instituto Joinvilense de Hematologia e Oncologia Ltda Centro de Hematologia e Oncologia
      • Natal, Brasil, 59075-740
        • Liga Norte Riograndense Contra O Cancer
      • Pelotas, Brasil, 96020 080
        • UPCO Unidade de Pesquisa Clinica em Oncologia
      • Porto Alegre, Brasil, 90020-090
        • Irmandade Santa Casa de Misericordia de Porto Alegre
      • Porto Alegre, Brasil, 90160-093
        • Hospital Ernesto Dornelles
      • Recife, Brasil, CEP: 50070
        • MultiHemo Servicos Medicos S.A
      • Rio de Janeiro, Brasil, 20551-030
        • Universidade do Estado do Rio de Janeiro - UERJ
      • Rio de Janeiro, Brasil, 22250 905
        • Oncoclinicas Rio de Janeiro S A
      • Rio de Janeiro, Brasil, 20230-130
        • Ministerio da Saude Instituto Nacional do Cancer
      • Rio de Janeiro, Brasil, 22775 001
        • Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
      • Salvador, Brasil, 40170 110
        • Nucleo de Oncologia da Bahia
      • Salvador, Brasil, 41253 190
        • Hospital Sao Rafael
      • Santo André, Brasil, 09060 870
        • Fundacao do ABC Centro Universitario FMABC
      • Sorocaba, Brasil, 18030-005
        • IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado
      • São Paulo, Brasil, 04014-002
        • Núcleo de Pesquisa São Camilo
      • São Paulo, Brasil, 01236-030
        • Instituto de Ensino e Pesquisa São Lucas
      • São Paulo, Brasil, 01221 020
        • Instituto do Cancer Arnaldo Vieira de Carvalho
      • São Paulo, Brasil, 04039-004
        • Instituto de Assistencia Medica ao Servidor Publico Estadual IAMSPE
      • São Paulo, Brasil, 01246 000
        • Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo
      • São Paulo, Brasil, 01221-020
        • Irmandade Santa Casa de Misericordia de Sao Paulo
      • São Paulo, Brasil, 01421-000
        • Hospital Alemao Oswaldo Cruz
      • São Paulo, Brasil, 01323 900
        • Real e Benemerita Associacao Portuguesa de Beneficencia
      • Uberlândia, Brasil, 38408-150
        • Centro Oncológico do Triângulo
      • Burgas, Bulgaria, 8001
        • MHAT Deva Maria
      • Pleven, Bulgaria, 5800
        • UMHAT Dr Georgi Stranski EAD 1
      • Plovdiv, Bulgaria, 4004
        • Complex Oncology Center - Plovdiv EOOD
      • Sofia, Bulgaria, 1756
        • Specialized Hospital for Active Treatment in Oncology
      • Sofia, Bulgaria, 1797
        • UMHAT Sofia Med
      • Sofia, Bulgaria, 1330
        • Multifunctional Hospital for Active Treatment for Women Health Nadezhda
      • Vratsa, Bulgaria, 3001
        • Comprehensive Cancer Center
    • Alberta
      • Calgary, Alberta, Canada, T2V 1P9
        • Prostate Cancer Centre
      • Edmonton, Alberta, Canada, T6G 1Z2
        • Cross Cancer Institute
    • British Columbia
      • Kelowna, British Columbia, Canada, V1Y 5L3
        • British Columbia Cancer Agency(BCCA)-Sindi Ahluwalia Hawkins Centre for the Southern Interior(CSI)
      • Vancouver, British Columbia, Canada, V5Z 4E6
        • British Columbia Cancer Agency BCCA Vancouver Centre
      • Victoria, British Columbia, Canada, V8R 6V5
        • British Columbia Cancer Agency Vancouver Island Centre
    • Ontario
      • Hamilton, Ontario, Canada, L8N 4A6
        • McMaster Institute of Urology
      • Kingston, Ontario, Canada, K7L2V7
        • Kingston Health Sciences Centre, Kingston General Health Research Institute
      • Toronto, Ontario, Canada, M5G2M9
        • Princess Margaret Cancer Centre University Health Network
      • Toronto, Ontario, Canada, M4N 3M5
        • Sunnybrook Health Sciences Center
    • Quebec
      • Montreal, Quebec, Canada, H3T 1E2
        • McGill University - Jewish General Hospital
      • Montreal, Quebec, Canada, H2X 0A9
        • Centre Hospitalier de l'Universite de Montreal
      • Aalborg, Danmark, 9000
        • Aalborg University Hospital
      • Copenhagen, Danmark, 2100
        • Copenhagen University Hospital
      • Herlev, Danmark, DK-2730
        • Herlev Hospital
      • Næstved, Danmark, 4700
        • Næstved Hospital
      • Odense, Danmark, DK-5000
        • Odense Universitetshospital
      • Vejle, Danmark, DK-7100
        • Vejle Hospital
    • Alabama
      • Homewood, Alabama, Forente stater, 35209
        • Urology Centers Of Alabama
    • Arizona
      • Phoenix, Arizona, Forente stater, 85054
        • Mayo Clinic Arizona
      • Tucson, Arizona, Forente stater, 85741
        • Urological Associates of Southern Arizona, P.C.
    • California
      • Los Angeles, California, Forente stater, 90073
        • Greater Los Angeles VA Healthcare System
      • Orange, California, Forente stater, 92868
        • University of California Irvine Medical Center Chao Family Comprehensive Cancer Center
      • San Bernardino, California, Forente stater, 92404
        • San Bernardino Urological Associates
      • San Francisco, California, Forente stater, 94158
        • University of San Francisco California
    • Colorado
      • Colorado Springs, Colorado, Forente stater, 80907
        • Rocky Mountain Cancer Centers
      • Denver, Colorado, Forente stater, 80210
        • AdventHealth Medical Group Urology of Denver
      • Lakewood, Colorado, Forente stater, 80228
        • Colorado Clinical Research
    • Connecticut
      • Norwich, Connecticut, Forente stater, 06360
        • Eastern Connecticut Hematology & Oncology Assoc.
    • Florida
      • Daytona Beach, Florida, Forente stater, 32114
        • Advanced Urology Institute
      • Fort Lauderdale, Florida, Forente stater, 33308
        • Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center
      • Jacksonville, Florida, Forente stater, 32256
        • Cancer Specialists of North Florida
      • Jacksonville, Florida, Forente stater, 32209
        • University of Florida Health Jacksonville
    • Indiana
      • Greenwood, Indiana, Forente stater, 46143
        • Urology of Indiana
      • Jeffersonville, Indiana, Forente stater, 47130
        • First Urology
    • Louisiana
      • New Orleans, Louisiana, Forente stater, 70121
        • Ochsner Clinic Foundation
    • Maryland
      • Baltimore, Maryland, Forente stater, 21201
        • Baltimore VA Medical Center
      • Columbia, Maryland, Forente stater, 21044
        • Maryland Oncology Hematology, PA
      • Towson, Maryland, Forente stater, 21204
        • Chesapeake Urology Associates
    • Michigan
      • Troy, Michigan, Forente stater, 48084
        • Michigan Institute of Urology
    • Missouri
      • Saint Joseph, Missouri, Forente stater, 64507
        • Mosaic Life Care
      • St Louis, Missouri, Forente stater, 63109
        • St. Louis VA Medical Center
    • Nebraska
      • Omaha, Nebraska, Forente stater, 68130
        • GU Research Network
    • New York
      • Albany, New York, Forente stater, 12206
        • New York Oncology Hematology
      • New York, New York, Forente stater, 10065
        • Memorial Sloan Kettering Cancer Center
      • New York, New York, Forente stater, 10029
        • Mount Sinai
      • New York, New York, Forente stater, 10010
        • Manhattan VAMC
      • Syracuse, New York, Forente stater, 13210
        • Associated Medical Professionals
      • The Bronx, New York, Forente stater, 10461
        • Montefiore Medical Center
    • North Carolina
      • Durham, North Carolina, Forente stater, 27705
        • Durham VAMC
    • Oklahoma
      • Oklahoma City, Oklahoma, Forente stater, 73104
        • Stephenson Cancer Center
    • Oregon
      • Portland, Oregon, Forente stater, 97239
        • VA Portland Health Care System
      • Salem, Oregon, Forente stater, 97301
        • Oregon Oncology Specialists
    • Pennsylvania
      • Lancaster, Pennsylvania, Forente stater, 17604
        • Keystone Urology Specialists
      • Philadelphia, Pennsylvania, Forente stater, 19104
        • University of Pennsylvania
      • Philadelphia, Pennsylvania, Forente stater, 19104
        • Philadelphia VA Medical Center
      • Pittsburgh, Pennsylvania, Forente stater, 15232
        • University of Pittsburgh Medical Center (UPMC)
    • South Carolina
      • Charleston, South Carolina, Forente stater, 29401
        • Ralph H. Johnson Veterans Affairs Medical Center
      • Seneca, South Carolina, Forente stater, 29672
        • Prisma Health
    • Tennessee
      • Nashville, Tennessee, Forente stater, 37209
        • Urology Associates
    • Texas
      • Austin, Texas, Forente stater, 78731
        • Texas Oncology-Austin
      • Denton, Texas, Forente stater, 76201
        • Texas Oncology - Northeast
      • Houston, Texas, Forente stater, 77027
        • Houston Metro Urology
      • New Braunfels, Texas, Forente stater, 78130
        • Texas Oncology P A
      • Tyler, Texas, Forente stater, 75702
        • Texas Oncology - Northeast 1
    • Utah
      • Salt Lake City, Utah, Forente stater, 84112
        • University of Utah Huntsman Cancer Institute
    • Virginia
      • Norfolk, Virginia, Forente stater, 23502
        • Virginia Oncology Associates
      • Richmond, Virginia, Forente stater, 23298
        • Virginia Commonwealth University - Massey Cancer Center
    • Washington
      • Seattle, Washington, Forente stater, 98109
        • Fred Hutchinson Cancer Research Center
      • Seattle, Washington, Forente stater, 98108
        • VA Puget Sound Healthcare System
      • Tacoma, Washington, Forente stater, 98405
        • MultiCare Health System
      • Angers, Frankrike, 49933
        • Institut de Cancerologie de l Ouest ICO
      • Avignon, Frankrike, 84918
        • Institut Sainte Catherine
      • Besançon, Frankrike, 25030
        • CHRU De Besancon
      • Bordeaux, Frankrike, 33000
        • Institut Bergonie
      • Clermont-Ferrand, Frankrike, 63011
        • Centre Jean Perrin
      • Dijon, Frankrike, 21000
        • Centre Georges Francois Leclerc
      • Lille, Frankrike, 59000
        • Centre Oscar Lambret
      • Lyon, Frankrike, 69008
        • Hopital Prive Jean Mermoz
      • Lyon, Frankrike, 69008
        • Centre Leon Berard
      • Montpellier, Frankrike, 34298
        • Institut Regional du Cancer de Montpellier Val d'Aurelle
      • Nancy, Frankrike, 54100
        • Polyclinique de Gentilly
      • Poitiers, Frankrike, 86021
        • CHU De Poitiers
      • Quimper, Frankrike, 29000
        • Centre Hopitalier Inter-Communal De Cornouaille
      • Saint-Mandé, Frankrike, 94163
        • HIA Begin
      • Saint-Priest-en-Jarez, Frankrike, 42271
        • Institut de Cancérologie de Loire
      • Strasbourg, Frankrike, 67000
        • Clinique Sainte Anne
      • Suresnes, Frankrike, 32151
        • Hopital Foch
      • Tours, Frankrike, 37044
        • CHRU de Tours
      • Babruysk, Hviterussland, 213825
        • Bobruisk Interregional Oncology Dispensary
      • Brest, Hviterussland, 224027
        • Brest Regional Oncology Dispensary
      • Grodno, Hviterussland, 230017
        • Grodno University Hospital
      • Homyel, Hviterussland, 246012
        • Gomel Regional Clinical Oncology Dispensary
      • Lesnoy, Hviterussland, 223040
        • N N Alexandrov National Cancer Centre of Belarus
      • Minsk, Hviterussland, 220013
        • Minsk city Clinical Oncological Dispensary
      • Mogilev, Hviterussland, 212018
        • Mogilev Regional Oncology Dispensary
      • Vitebsk, Hviterussland, 210603
        • Vitebsk Regional Clinical Oncology Dispensary
      • Afula, Israel, 1834111
        • Haemek Medical Center - Afula
      • Beersheba, Israel, 85101
        • Soroka Hospital
      • Haifa, Israel, 31096
        • Rambam Medical Center
      • Jerusalem, Israel, 91200
        • Hadassah Hospital
      • Petach Tikvah, Israel, 49100
        • Rabin Medical Center, Beilinson Hospital
      • Ramat Gan, Israel, 52621
        • Sheba Medical Center Tel Hashomer
      • Tel Aviv, Israel, 64239
        • Tel Aviv Sourasky Medical Center
      • Arezzo, Italia, 52100
        • Ospedale S. Donato - Asl 8 Arezzo
      • Candiolo, Italia, 10060
        • Divisione di Oncologia - Istituto per la ricerca e cura del cancro
      • Cremona, Italia, 26100
        • Istituti Ospitalieri di Cremona, AO di Cremona
      • Lecce, Italia, 73100
        • Azienda Ospedaliera ''Vito Fazzi''
      • Meldola, Italia, 47014
        • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
      • Milan, Italia, 20132
        • Ospedale San Raffaele
      • Milan, Italia, 20133
        • Fondazione IRCCS Istituto Nazionale dei Tumori
      • Milan, Italia, 20141
        • European Institute of Oncology
      • Naples, Italia, 80138
        • Fondazione G Pascale Istituto Nazionale Tumori IRCCS
      • Orbassano, Italia, 10043
        • Aou San Luigi Gonzaga
      • Padova, Italia, 35128
        • Istituto Oncologico Veneto Iov Irccs Padova
      • Pisa, Italia, 56126
        • Azienda Ospedaliero Universitaria Pisana
      • Pozzuoli, Italia, 80078
        • ASL Napoli 2 Nord-SM delle Grazie Hospital
      • San Giovanni Rotondo, Italia, 71013
        • Casa Sollievo Della Sofferenza IRCCS
      • Trento, Italia
        • Ospedale S. Chiara
      • Vicenza, Italia, 36100
        • Ospedale San Bortolo
      • Beijing, Kina, 100142
        • Beijing Cancer Hospital
      • Beijing, Kina, 100730
        • Beijing Hospital
      • Beijing, Kina, 100034
        • Peking University First Hospital
      • Beijing, Kina, 100021
        • Cancer Hospital Chinese Academy of Medical Sciences
      • Beijing, Kina, 100191
        • Beijing University Third Hospital
      • Beijing, Kina, 100050
        • Beijing Friendship Hospital Capital Medical University
      • Chengdu, Kina, 610041
        • West China Hospital of Sichuan University
      • Chengdu, Kina, 610083
        • Western Theater General Hospital of the Chinese People's Liberation Army
      • Chengdu, Kina, 610072
        • Sichuan Provincial Peoples Hospital
      • Chongqing, Kina, 400030
        • Chongqing University Cancer Hospital
      • Chongqing, Kina, 400038
        • Southwest Hospital, The Third Military Medical University
      • Guangzhou, Kina, 510180
        • Guangzhou First Municipal People's Hospital
      • Guangzhou, Kina, 510289
        • Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
      • Guangzhou, Kina, 430030
        • Sun Yat Sen University Cancer Center
      • Hangzhou, Kina, 310014
        • Zhejiang Provincial People's Hospital
      • Nanchang, Kina, 330006
        • The First Affiliated Hospital of NanChang University
      • Nanjing, Kina, 210008
        • Nanjing Drum Tower Hospital
      • Nanjing, Kina, 210000
        • Jiangsu Province Cancer Hospital
      • Ningbo, Kina, 315010
        • The First Affiliated Hospital of Ningbo University
      • Shanghai, Kina, 200032
        • Fudan University Shanghai Cancer Center
      • Shanghai, Kina, 200040
        • Huashan Hospital Fudan University
      • Shanghai, Kina, 200240
        • The Fifth People's Hospital of Shanghai, Fudan University
      • Shanghai, Kina, 200127
        • Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University
      • Shanghai, Kina, 200400
        • Huadong Hospital Affiliated to Fudan University
      • Shenyang, Kina, 110004
        • Shengjing Hospital Of China Medical University
      • Suzhou, Kina, 215006
        • The First Affliated Hospital of Soochow University
      • Suzhou, Kina, 200233
        • Second Affiliated Hospital of Soochow University
      • Wenzhou, Kina, 325000
        • The First Affiliated Hospital of Wenzhou Medical University
      • Wuhan, Kina, 430030
        • TongJi Hospital of TongJi Medical College of Huazhong University of Science & Technology
      • Xi'an, Kina, 710061
        • The First Affiliated Hospital of Xian Jiaotong University
      • George Town, Malaysia, 10990
        • Hospital Pulau Pinang
      • Johor Bahru, Malaysia, 81100
        • Hospital Sultan Ismail
      • Kuala Lumpur, Malaysia, 50586
        • Hospital Kuala Lumpur
      • Kuala Lumpur, Malaysia, 59100
        • University Malaya Medical Centre
      • Kuching, Malaysia, 93586
        • Sarawak General Hospital
      • Putrajaya, Malaysia, 62250
        • Institut Kanser Negara Clinical Research Center
      • Durango, Mexico, 34000
        • Consultorio de Especialidad en Urologia Privado
      • León, Mexico, 37000
        • Consultorio Privado
      • Mexico City, Mexico, 3720
        • Centro de Investigacion Clínica Gramel S.C.1
      • Monterrey, Mexico, 64710
        • i Can Oncology Center
      • Monterrey, Mexico, 64710
        • Avix Investigacion Clinica S C
      • Naucalpan, Mexico, 53100
        • Oncologia Integral Satelite
      • Oaxaca City, Mexico, 68020
        • Centro de Investigacion Clinica de Oaxaca
      • Zapopan, Mexico, 45040
        • Consultorio Privado 1
      • Delft, Nederland, 2625 AD
        • Reinier de Graaf Gasthuis
      • Hilversum, Nederland, 1213XZ
        • Tergooiziekenhuizen
      • Nijmegen, Nederland, 6532 SZ
        • Canisius-Wilhelminaziekenhuis
      • Tilburg, Nederland, 5022 GC
        • Elisabeth-TweeSteden Ziekenhuis
      • Auckland, New Zealand, 1023
        • Auckland City Hospital
      • Christchurch, New Zealand, 8013
        • Canterbury Urology Research Trust
      • Dunedin Central, New Zealand, 9016
        • Dunedin Hospital
      • Tauranga, New Zealand, 3112
        • Tauranga Hospital
      • Bydgoszcz, Polen, 85 048
        • IN VIVO Sp. z o.o
      • Bydgoszcz, Polen, 85 094
        • Szpital Uniwersytecki NR 1 IM Dr Antoniego Jurasza
      • Bydgoszcz, Polen, 85 796
        • Centrum Onkologii im Prof F Lukaszczyka
      • Gdynia, Polen, 81 519
        • Szpitale Pomorskie Sp z o o
      • Konin, Polen, 62-500
        • Przychodnia Lekarska KOMED Roman Karaszewski
      • Krakow, Polen, 30 539
        • Klinika MedTrials
      • Lodz, Polen, 93-509
        • Wojewodzki Szpital Specjalistyczny im. M. Kopernika w Lodzi
      • Lublin, Polen, 20-223
        • Medisport
      • Siedlce, Polen, 08-110
        • Urologica Praktyka Lekarska Adam Marcheluk
      • Warsaw, Polen, 04 073
        • Szpital Grochowski Im Dr Med Rafala Masztaka Sp Z O O
      • Wroclaw, Polen, 53-329
        • Specjalistyczna przychodnia lekarska POLIMED
      • Almada, Portugal, 2805-607
        • Uls Almada Seixal - Hosp. Garcia de Orta
      • Coimbra, Portugal, 3000075
        • Instituto Português de Oncologia Francisco Gentil - Centro Regional de Oncologia de Coimbra, S.A.
      • Lisbon, Portugal, 1400-038
        • Fund. Champalimaud
      • Lisbon, Portugal, 1649 035
        • Uls Santa Maria - Hosp. Santa Maria
      • Hato Rey, Puerto Rico, 00917
        • Puerto Rico Medical Research Center
      • Barnaul, Russland, 656045
        • Altai Regional Oncology Dispensary
      • Chelyabinsk, Russland, 454087
        • Chelyabinsk Regional Clinical Center Of Oncology And Nuclear Medicine
      • Ivanovo, Russland, 153040
        • Ivanovo Regional Oncology Dispensary
      • Moscow, Russland, 125130
        • Moscow City Clinical Hospital # 62
      • Moscow, Russland, 125284
        • Hertzen Oncology Research Institute
      • Nizhny Novgorod, Russland, 603001
        • Privolzhsky District Medical Centre
      • Omsk, Russland, 644013
        • Clinical Oncology Dispensary
      • Pyatigorsk, Russland, 357500
        • LLC Novaya Clinica
      • Pyatigorsk, Russland, 357502
        • Pyatigorsk Interdistrict Oncology Dispensary
      • Saint Petersburg, Russland, 196603
        • Private Medical Institution Euromedservice
      • Saint Petersburg, Russland, 191104
        • Leningrad Regional Oncology Dispensary
      • Saransk, Russland, 430032
        • Republican Oncology Dispensary
      • Tomsk, Russland, 634050
        • Tomsk Cancer Research Institute
      • Tyumen, Russland, 625041
        • Multifunctional clinical medical center 'Medical city'
      • Ufa, Russland, 450083
        • Bashkir State Medical University
      • A Coruña, Spania, 15006
        • Hosp Univ A Coruna
      • Barcelona, Spania, 08025
        • Hosp. de La Santa Creu I Sant Pau
      • Barcelona, Spania, 08036
        • Hosp Clinic de Barcelona
      • Castellon, Spania, 12004
        • Hosp. Gral. Univ. de Castellon
      • Girona, Spania, 17007
        • Institut Català D'Oncologia Girona
      • Jerez de la Frontera, Spania, 11407
        • Hosp. de Jerez de La Frontera
      • Madrid, Spania, 28041
        • Hosp. Univ. 12 de Octubre
      • Madrid, Spania, 28034
        • Hosp. Univ. Ramon Y Cajal
      • Madrid, Spania, 28046
        • Hosp. Univ. La Paz
      • Madrid, Spania, 28006
        • Hosp. Univ. de La Princesa
      • Madrid, Spania, 28660
        • Hosp. Univ. Hm Monteprincipe
      • Málaga, Spania, 29010
        • Hosp Virgen de La Victoria
      • Sabadell, Spania, 08208
        • Corporacio Sanitari Parc Tauli
      • Santander, Spania, 39008
        • Hosp. Univ. Marques de Valdecilla
      • Seville, Spania, 41013
        • Hosp. Virgen Del Rocio
      • Valencia, Spania, 46010
        • Hosp. Clinico Univ. de Valencia
      • Bangor, Storbritannia, LL57 2PW
        • Ysbyty Gwynedd
      • Belfast, Storbritannia, BT9 7AB
        • Belfast City Hospital
      • Brighton, Storbritannia, BN2 5BE
        • Brighton and Sussex University Hospitals NHS Trust
      • Bristol, Storbritannia, BS2 8ED
        • Bristol Haematology and Oncology Centre
      • Great Maze Pond, Storbritannia, SE1 9RT
        • Guy's Hospital
      • Grimsby, Storbritannia, DN33 2BA
        • Prince Of Wales Hospital
      • Hillingdon, Storbritannia, HA6 2RN
        • Marie Curie Research Wing - Mount Vernon Hospital
      • Inverness, Storbritannia, IV2 3UJ
        • Raigmore Hospital
      • London, Storbritannia, NW1 2PG
        • University College London Hospitals NHSFT
      • Oxford, Storbritannia, OX3 7LE
        • Churchill Hospital
      • Preston, Storbritannia, PR2 9HT
        • Royal Preston Hospital
      • Sutton, Storbritannia, SM2 5PT
        • Royal Marsden Hospital
      • Truro, Storbritannia, TR1 3LJ
        • Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital
      • Gothenburg, Sverige, 413 45
        • Salgrenska University hospital
      • Malmö, Sverige, 205 02
        • Urologiska Mottagningen
      • Stockholm, Sverige, 17164
        • Karolinska Universitetssjukhuset Solna
      • Stockholm, Sverige, 11883
        • Sodersjukhuset
      • Busan, Sør -Korea, 49241
        • Pusan National University Hospital
      • Daegu, Sør -Korea, 41404
        • Kyungpook National University Chilgok Hospital
      • Daegu, Sør -Korea, 42601
        • Keimyung University Dongsan Hospital
      • Daejeon, Sør -Korea, 35015
        • Chungnam National University Hospital
      • Gwangju, Sør -Korea, 61469
        • Chonnam National University Hospital
      • Gyeonggi-do, Sør -Korea, 10408
        • National Cancer Center
      • Seongnam-si, Sør -Korea, 13620
        • Seoul National University Bundang Hospital
      • Seoul, Sør -Korea, 03080
        • Seoul National University Hospital
      • Seoul, Sør -Korea, 05505
        • Asan Medical Center
      • Seoul, Sør -Korea, 03722
        • Severance Hospital Yonsei University Health System
      • Seoul, Sør -Korea, 06351
        • Samsung Medical Center
      • Seoul, Sør -Korea, 06591
        • The Catholic University of Korea Seoul St Mary s Hospital
      • Seoul, Sør -Korea, 06273
        • Gangnam Severance Hospital, Yonsei University Health System
      • Suwon, Sør -Korea, 16499
        • Ajou University Hospital
      • Cape Town, Sør-Afrika, 7700
        • CancerCare Rondebosch
      • Pretoria, Sør-Afrika, 0001
        • Steve Biko Academic Hospital
      • Vosloorus, Sør-Afrika, 1475
        • East Rand Urology Research Unit
      • Kaohsiung City, Taiwan, 83301
        • Kaohsiung Chang Gung Memorial Hospital
      • Kaohsiung City, Taiwan, 807
        • Kaohsiung Medical University Chung Ho Memorial Hospital
      • Taichung, Taiwan, 40447
        • China Medical University Hospital
      • Taichung, Taiwan, 40705
        • Taichung Veterans General Hospital
      • Taichung, Taiwan, 435
        • Tungs' Taichung MetroHarbor Hospital
      • Taipei, Taiwan, 10002
        • National Taiwan University Hospital
      • Taipei, Taiwan, 11217
        • Taipei Veterans General Hospital
      • Taoyuan, Taiwan, 333
        • Chang-Gung Memorial Hospital, LinKou Branch
      • Bangkok, Thailand, 10330
        • King Chulalongkorn Memorial Hospital
      • Bangkok, Thailand, 10700
        • Siriraj Hospital
      • Bangkok, Thailand, 10400
        • Ramathibodi Hospital
      • Brno, Tsjekkia, 656 91
        • Fakultni nemocnice u sv. Anny v Brne
      • Hradec Králové, Tsjekkia, 500 05
        • FN Hradec Kralove, Urologicka klinika
      • Liberec, Tsjekkia, 460 63
        • Krajská nemocnice Liberec
      • Olomouc, Tsjekkia, 77900
        • Uromedical Center s.r.o.
      • Prague, Tsjekkia, 128 00
        • Urologicka klinika 1 LF UK a VFN
      • Adana, Tyrkia (Türkiye), 01250
        • Adana Baskent Yuregir Hospital
      • Ankara, Tyrkia (Türkiye), 06520
        • Memorial Ankara Hastanesi
      • Ankara, Tyrkia (Türkiye), 06800
        • Ankara Bilkent Sehir Hastanesi
      • Ankara, Tyrkia (Türkiye), 06590
        • Ankara University Medical Faculty
      • Ankara, Tyrkia (Türkiye), 06200
        • Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi
      • Ankara, Tyrkia (Türkiye), 06560
        • Gazi Hastanesi
      • Bursa, Tyrkia (Türkiye), 16310
        • Bursa Yuksek lhtisas EAH Medikal Onkoloji Klinigi
      • Edirne, Tyrkia (Türkiye), 22030
        • Trakya University Medical Faculty
      • Istanbul, Tyrkia (Türkiye), 34147
        • Bakirkoy Training and Research Hospital
      • Istanbul, Tyrkia (Türkiye), 34000
        • Istanbul University Istanbul Medical Faculty
      • Istanbul, Tyrkia (Türkiye), 34098
        • Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd
      • Istanbul, Tyrkia (Türkiye), 34722
        • T C Saglik Bakanlıgi Goztepe Prof Dr Suleyman Yalcın Sehir Hastanesi
      • Izmir, Tyrkia (Türkiye), 35530
        • Izmir Medical Point Hospital
      • Izmir, Tyrkia (Türkiye), 35340
        • Dokuz Eylul Universitesi Arastirma ve Uygulama Hastanesi
      • Sakarya, Tyrkia (Türkiye), 54050
        • Sakarya Üniversitesi Tıp Fakültesi Hastanesi
      • Samsun, Tyrkia (Türkiye), 55200
        • Medical Park Samsun Hastanesi
      • Braunschweig, Tyskland, 38126
        • Städtisches Klinikum Braunschweig gGmbH - Standort Salzdahlumer
      • Cologne, Tyskland, 50937
        • Universitaetsklinikum Koelnt
      • Dresden, Tyskland, 01307
        • Universitätsklinik Carl Gustav Carus, Med. Klinik u. Poliklinik I
      • Duisburg, Tyskland, 47169
        • Urologicum Duisburg
      • Hanover, Tyskland, 30625
        • Medizinische Hochschule Hannover
      • München, Tyskland, 81675
        • Klinikum rechts der Isar - III. Med. Klinik und Poliklinik
      • Münster, Tyskland, 48149
        • Universitaetsklinikum Muenster
      • Nürtingen, Tyskland, 72622
        • Studienpraxis Urologie Drs. Feyerabend
      • Cherkasy, Ukraina, 18009
        • CNE Clinical Center of Oncology Hematology Transplantology and Palliative Care of the Cherkasy RC
      • Chernivtsi, Ukraina, 58013
        • Municipal Non-profit enterprise 'Bukovinian clinical oncology center'
      • Dnipro, Ukraina, 49102
        • Dnipropetrovsk State Medical Academy, Dnipropetrovsk City Multifield Clinical Hospital # 4
      • Dnipro, Ukraina, 49100
        • Municipal Institution 'Clinical Oncology Dispensary' Under Dnipropetrovsk Regional Council
      • Dnipro, Ukraina, 49005
        • Ce 'Dnipropetrovsk Regional Clinical Hospital N.A. Mechnikov' of Dnipropetrovsk Rc
      • Ivano-Frankivsk, Ukraina, 76008
        • Ivano-Frankivsk Regional Clinical Hospital
      • Kamyanske, Ukraina, 51900
        • Communal Institution 'City hospital №7 of Kamianske' of Dnepropetrov'sk Regional Council
      • Khakhiv, Ukraina, 61070
        • Municipal non-profit enterprise 'Regional Center of Oncology'
      • Kharkiv, Ukraina, 61037
        • Regional Medical Clinical Center for Urology and Nephrology named after V.I. Shapoval
      • Kherson, Ukraina, 73035
        • Kherson Regional Oncological Dispensary
      • Kyiv, Ukraina, 04107
        • Kyiv Regional Oncological Dispensary
      • Kyiv, Ukraina, 03115
        • State Institution Institute of Urology NAMS of Ukraine based on Kyiv City Clinical Oncology Center
      • Kyiv, Ukraina, 03022
        • State Nonprofit Enterprise National Cancer Institute
      • Lviv, Ukraina, 79010
        • Communal Noncommercial Enterprise of Lviv Regional Council 'Lviv Regional Clinical Hospital'
      • Vinnitsa, Ukraina, 21029
        • Podilskiy Regional Center of Oncology
      • Zhytomyr, Ukraina, 10002
        • Municipal non-profit enterprise Zhytomyr Regional Oncology Dispensary of Zhytomyr Regional Council
      • Budapest, Ungarn, 1204
        • Jahn Ferenc Del-pesti Korhaz es Rendelointezet
      • Debrecen, Ungarn, 4032
        • Debreceni Egyetem
      • Gyula, Ungarn, 5700
        • Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz
      • Győr, Ungarn, 9024
        • Petz Aladar Megyei Oktato Korhaz
      • Miskolc, Ungarn, 3526
        • Borsod Abauj Zemplen Varmegyei Kozponti Korhaz es Egyetemi Oktato Korhaz
      • Szeged, Ungarn, 6720
        • Szegedi Tudomanyegyetem
      • Tatabánya, Ungarn, 2800
        • Szent Borbala Hospital Tatabanya

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Mann

Beskrivelse

Inclusion criteria:

  • Pathological diagnosis of prostate adenocarcinoma
  • Must have appropriate deleterious homologous recombination repair (HRR) gene alteration
  • Metastatic disease as documented by conventional imaging with computed tomography (CT) or magnetic resonance imaging (MRI) (for soft tissue lesions) or 99mTc bone scan (for bone lesions). Participants with a single bone lesion on Technetium-99m (99mTc) bone scan with no other non-nodal metastatic disease must have confirmation of bone metastasis by CT or MRI. Participants with lymph node-only disease are not eligible
  • Androgen deprivation therapy (either medical or surgical castration) must have been started >=14 days prior to randomization and participants be willing to continue androgen deprivation therapy (ADT) through the treatment phase
  • Other allowed prior therapy for metastatic castration-sensitive prostate cancer (mCSPC): (a) maximum of 1 course of radiation and 1 surgical intervention for symptomatic control of prostate cancer (example, uncontrolled pain, impending spinal cord compression or obstructive symptoms). Participants with radiation or surgical interventions to all known sites of metastatic disease will be excluded from trial participation. Radiation must be completed prior to randomization (b) Up to a maximum of 6 months of ADT prior to randomization; (c) Up to a maximum of 45 days of abiraterone acetate + prednisone (AA-P) prior to randomization (d) Up to a maximum of 2 weeks of ketoconazole for prostate cancer prior to randomization

Exclusion criteria:

  • Prior treatment with a poly (adenosine diphosphate-ribose) polymerase inhibitor (PARP inhibitor)
  • History of adrenal dysfunction
  • Long-term use of systemically administered corticosteroids (greater than [>] 5 milligrams [mg] of prednisone or the equivalent) during the study is not allowed. Short-term use (<=4 weeks, including taper) and locally administered steroids (for example, inhaled, topical, ophthalmic, and intra-articular) are allowed, if clinically indicated
  • History or current diagnosis of myelodysplastic syndrome (MDS)/ acute myeloid leukemia (AML)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Trippel

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Niraparib with Abiraterone Acetate plus Prednisone (AAP)

Participants will receive the following in each 28-day treatment cycle: niraparib 200 milligrams (mg) + abiraterone acetate (AA) 1000 mg fixed dose combination (FDC) along with placebo for AA and prednisone 5 mg once daily.

Participants will receive a FDC of Niraparib 200 mg + AA 1000 mg once daily.

Participants will receive prednisone 5 mg once daily.

Participants will receive matching placebo for AA once daily.

Aktiv komparator: Placebo for Niraparib + AA FDC plus AA and prednisone (AAP)

Participants will receive the following in each 28-day treatment cycle: matching placebo for Niraparib+AA FDC along with AA 1000 mg and prednisone 5 mg once daily.

Participants will receive prednisone 5 mg once daily.

Participants will receive AA 1000 mg once daily.

Participants will receive matching placebo for Niraparib +AA FDC once daily.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Breast Cancer Gene (BRCA) Subgroup: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
Tidsramme: From date of randomization (Day -3 to Day 1) up to approximately 49 months

rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by computerized tomography (CT) or magnetic resonance imaging (MRI) per response evaluation criteria in solid tumors (RECIST) 1.1; (2) progression of bone lesions observed by bone scan per prostate cancer working group 3 (PCWG3) criteria: bone progression was confirmed by subsequent scan greater than or equal to (>=) 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later.

From date of randomization (Day -3 to Day 1) up to approximately 49 months
HRR Effector Subgroup: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
Tidsramme: From date of randomization (Day -3 to Day 1) up to approximately 49 months

rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by CT or MRI per RECIST 1.1; (2) progression of bone lesions observed by bone scan per PCWG3 criteria: bone progression was confirmed by subsequent scan >= 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later.

From date of randomization (Day -3 to Day 1) up to approximately 49 months
All HRR: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
Tidsramme: From date of randomization (Day -3 to Day 1) up to approximately 49 months

rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by CT or MRI per RECIST 1.1; (2) progression of bone lesions observed by bone scan per PCWG3 criteria: bone progression was confirmed by subsequent scan >= 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later.

From date of randomization (Day -3 to Day 1) up to approximately 49 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Overlevelse (OS)
Tidsramme: Fra randomiseringsdato (dag -3 til dag 1) opp til 83 måneder
Fra randomiseringsdato (dag -3 til dag 1) opp til 83 måneder
Tid til påfølgende behandling
Tidsramme: Fra randomiseringsdato (dag -3 til dag 1) opp til 83 måneder
Fra randomiseringsdato (dag -3 til dag 1) opp til 83 måneder
Antall deltakere med behandlingsrelaterte alvorlige bivirkninger
Tidsramme: Fra syklus 1 dag 1 opptil 83 måneder
Fra syklus 1 dag 1 opptil 83 måneder
Antall deltakere med behandlingsrelaterte bivirkninger etter alvorlighetsgrad
Tidsramme: Fra syklus 1 dag 1 opp til 83 måneder
Fra syklus 1 dag 1 opp til 83 måneder
BRCA Subgroup: Time to Symptomatic Progression
Tidsramme: From date of randomization (Day -3 to Day 1) up to approximately 49 months

Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms.

From date of randomization (Day -3 to Day 1) up to approximately 49 months
HRR Effector Subgroup: Time to Symptomatic Progression
Tidsramme: From date of randomization (Day -3 to Day 1) up to approximately 49 months

Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms.

From date of randomization (Day -3 to Day 1) up to approximately 49 months
All HRR: Time to Symptomatic Progression
Tidsramme: From date of randomization (Day -3 to Day 1) up to approximately 49 months

Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms.

From date of randomization (Day -3 to Day 1) up to approximately 49 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studieleder: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

23. september 2020

Primær fullføring (Faktiske)

7. januar 2025

Studiet fullført (Antatt)

1. november 2027

Datoer for studieregistrering

Først innsendt

31. juli 2020

Først innsendt som oppfylte QC-kriteriene

31. juli 2020

Først lagt ut (Faktiske)

4. august 2020

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

4. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

2. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • CR108852
  • 2020-002209-25 (EudraCT-nummer)
  • 67652000PCR3002 (Annen identifikator: Janssen Research & Development, LLC)
  • 2023-506365-64-00 (Registeridentifikator: EUCT number)
  • 2023 (U.S. NIH-stipend/kontrakt)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

The data sharing policy of Johnson & Johnson Innovative Medicine is available at innovativemedicine.jnj.com/our-innovation/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Ja

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere